Background: The Meningococcal Antigen Typing System (MATS) was developed to identify meningococcus group B strains with a high likelihood of being covered by the 4CMenB vaccine, but is limited by the requirement for viable isolates from culture-confirmed cases. We examined if antigen genotyping could complement MATS in predicting strain coverage by the 4CMenB vaccine. Methods: From a panel of 3912 MATS-typed in...
Texto completo: acesso restrito. p. 888-896; Submitted by Suelen Reis (suziy.ellen@gmail.com) on 2013-12-11T14:42:21Z No. of bitstreams: 1 10.1086528375.pdf: 3698045 bytes, checksum: bd8325c47814f7a0d9310921fae58372 (MD5); Approved for entry into archive by Alda Lima da Silva (sivalda@ufba.br) on 2014-01-21T21:10:06Z (GMT) No. of bitstreams: 1 10.1086528375.pdf: 3698045 bytes, checksum: bd8325c47814f7a0d9310921...